In this study nine patients with SBS were given infusions of GLP-1, a combination of GLP-2 and GLP-1+2, and a placebo at 1 pmol/kg/min. The gene discussed is GCG; the disease is macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.